Ketamine Intravenous (IV) Therapy is a unique and innovative approach to treating various psychiatric and chronic pain conditions, and it has garnered significant attention in the medical community. Originally developed as an anesthetic in the 1960s, ketamine has found renewed purpose as a powerful and fast-acting treatment for conditions such as depression, anxiety, post-traumatic stress disorder (PTSD), and chronic pain. Administered through intravenous infusion, ketamine therapy offers distinct advantages over traditional psychiatric medications. The most notable feature is its rapid onset of action. While conventional antidepressants may take weeks to produce noticeable effects, ketamine often induces a response within hours. This characteristic makes it particularly valuable for individuals in acute distress or those who have not responded to other treatments.
